VUF11403
CAS No. 1378524-61-8
VUF11403( VUF-11403 | VUF 11403 )
Catalog No. M11562 CAS No. 1378524-61-8
A potent CXCR7 (ACKR3) agonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameVUF11403
-
NoteResearch use only, not for human use.
-
Brief DescriptionA potent CXCR7 (ACKR3) agonist.
-
DescriptionA potent CXCR7 (ACKR3) agonist.
-
In Vitro——
-
In Vivo——
-
SynonymsVUF-11403 | VUF 11403
-
PathwayGPCR/G Protein
-
TargetChemokine Receptor
-
RecptorChemokine Receptor
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1378524-61-8
-
Formula Weight440.56
-
Molecular FormulaC26H33FN2O3
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC(=CC1=CC=CC=C1F)CN(CCC2CCCN2C)C(=O)C3=CC(=C(C=C3)OC)OC
-
Chemical Name(E)-N-(3-(2-Fluorophenyl)-2-methylallyl)-3,4-dimethoxy-N-(2-(1-methylpyrrolidin-2-yl)ethyl)benzamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Wijtmans M, et al. Eur J Med Chem. 2012 May;51:184-92.
molnova catalog
related products
-
LMD-A
LMD-A (CCR8 antagonist LMD-A) is a highly potent, small molecule antagonist of chemokine receptor CCR8 with EC50 of 2.5 nM.
-
GSK 163929
A potent, selective CCR5 antagonist and HIV-1 entry inhibitor with pIC50 of 8.37 and 8.46 in HOS and PBL assays, respectively.
-
TIQ-15
TIQ-15 is a potent and selective CXCR4 antagonist, inhibits attachment of X4 HIV-1IIIB virus in MAGI-CCR5/CXCR4 cells with IC50 of 3 nM.
Cart
sales@molnova.com